The Anti-Staphylococcal Lysin, CF-301, Activates Key Host Factors in Human Blood to Potentiate MRSA Bacteriolysis

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02291-18
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Postantibiotic and Sub-Mic Effects of Exebacase (Lysin CF-301) Enhance Antimicrobial Activity Against Staphylococcus Aureus

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Targeting Host Factors to Circumvent Anti-Malarial Drug Resistance

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2012English

Daratumumab in Combination With Urelumab to Potentiate Anti-Myeloma Activity in Lymphocyte-Deficient Mice Reconstituted With Human NK Cells

OncoImmunology
OncologyAllergyImmunology
2019English

the Staphylococcal Biofilm: Adhesins, Regulation, and Host Response

Microbiology spectrum
EcologyImmunologyCell BiologyMicrobiologyMicrobiology GeneticsInfectious DiseasesPhysiology
2016English

Anti-Hiv Chemotherapy Targeted at Host-Cellular Factors.

Uirusu. Journal of virology
Medicine
1996English

Biosynthetic Engineering of the Antifungal, Anti-Mrsa Auroramycin

Microbial Cell Factories
Applied MicrobiologyBiotechnologyBioengineering
2020English

Laspartomycin, a New Anti-Staphylococcal Peptide

Journal of Antibiotics
Drug DiscoveryPharmacology
1968English

Humanisation of the Zebrafish C5a Receptor Confers Targeting by Human-Specific Staphylococcal Virulence Factors.

2020English

KF-finder: Identification of Key Factors From Host-Microbial Networks in Cervical Cancer

BMC Systems Biology
Molecular BiologyApplied MathematicsStructural BiologySimulationComputer Science ApplicationsModeling
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy